Very clinically sizeable. Stay away from combinations; the potential risk of the conversation outweighs the gain. Whilst cannabis (marijuana) remains a federal DEA Schedule 1 controlled compound, research has resulted in progress and advertising and marketing of prescription drugs which might be synthetic prescription cannabinoid items. NIDA